Letters

Screening for breast cancer Randomised trials testify to benefit

BMJ 1994; 308 doi: https://doi.org/10.1136/bmj.308.6922.201d (Published 15 January 1994) Cite this as: BMJ 1994;308:201
  1. J M Dixon
  1. Department of Surgery, University of Edinburgh, Royal Infirmary, Edinburgh EH3 9YW.

    EDITOR, - Recent letters have criticised screening for breast cancer by mammography,1,2 which is the only method of screening for malignancy that has been shown to be of value in rigorous randomised trials. Harold Hewitt incorrectly states that there is no evidence that detection of breast cancers by screening eliminates dissemination.1 There is clear evidence that screening detects less aggressive cancers, which are less …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe